Metagenomi, Inc. (MGX)
NASDAQ: MGX · IEX Real-Time Price · USD
6.77
-0.13 (-1.81%)
May 10, 2024, 12:24 PM EDT - Market open
Metagenomi Revenue
In the year 2023, Metagenomi had annual revenue of $44.76M with 160.21% growth. Revenue in the quarter ending December 31, 2023 was $12.40M.
Revenue (ttm)
$44.76M
Revenue Growth
+160.21%
P/S Ratio
5.77
Revenue / Employee
$189,644
Employees
236
Market Cap
253.52M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 44.76M | 27.56M | 160.21% |
Dec 31, 2022 | 17.20M | 16.96M | 6,978.19% |
Dec 31, 2021 | 243.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMGX News
- 8 days ago - Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems - GlobeNewsWire
- 4 weeks ago - Metagenomi to Present at Upcoming Scientific Meetings - GlobeNewsWire
- 6 weeks ago - Metagenomi Reports Business Updates and Full Year 2023 Financial Results - GlobeNewsWire
- 2 months ago - Metagenomi to Participate in the 44th Annual Cowen Healthcare Conference - GlobeNewsWire
- 3 months ago - Metagenomi Announces Closing of Initial Public Offering - GlobeNewsWire
- 3 months ago - Moderna, Bayer-backed Metagenomi stock drops 32% on Nasdaq debut - Reuters
- 3 months ago - Moderna-backed Metagenomi cuts US IPO valuation target to $563 mln - Reuters
- 3 months ago - Metagenomi Announces Pricing of Initial Public Offering - GlobeNewsWire